Published May 13, 2024
| Version v1
Conference paper
Open
RECURRENCE OF CHCV AFTER THE USE OF DIRECT ANTIVIRAL DRUGS: CLINICS, DIAGNOSIS, TREATMENT AND OUTCOMES
Creators
- 1. Termez branch of the Tashkent Medical Academy
- 2. Infectious diseases hospital of Surkhandarya region
- 3. 5th year student of the Termez branch of the Tashkent Medical Academy
Description
Viral hepatitis C is one of the leading liver diseases. According to
WHO, 70 million people are infected with this disease. HCV kills 290,000 people
every year. In 95% of patients, the disease becomes chronic, and the main
complications are fibrosis and cirrhosis of the liver. In some cases, a relapse is
observed, despite treatment with antiviral drugs.
Files
Jurayev J.S.,98-99.pdf
Files
(166.3 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:5c1fafc8edb88db62a0bd72b0832cc7c
|
166.3 kB | Preview Download |
Additional details
References
- 1. Kuznetsov N.I., Romanova E.S., Startseva G.Yu. Modern principles of antiviral therapy for hepatitis C. // Russian Family Physician, Moscow 2018; 23-28. 2.
- Musabaev I.K., Musabaev E.I., Atabekov N.S. Hepatitis C: etiology, epidemiology, pathogenesis, clinical picture, differential diagnosis, therapy and prevention. – / Tashkent, 2000; 32-37
- 3. Khubutia M.Sh., Syutkin V.E., Zhuravel S.V., Novruzbekov M.S., Fedin A.B. The use of sobosfuvir for the treatment of hepatitis C after liver transplantation. // Clinical Medicine, Moscow 2017; 78-84